Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples